---
title: 'Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port
  Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
  and Diabetic Macular Edema in Clinical Practice'
date: '2024-02-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38304609/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240202170634&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: VOYAGER is an innovative study of retinal diseases that
  will assess the effectiveness and safety of faricimab and PDS in nAMD and DME and
  identify clinician- and disease-related factors driving treatment outcomes in clinical
  practices globally to help optimize vision ...'
disable_comments: true
---
CONCLUSIONS: VOYAGER is an innovative study of retinal diseases that will assess the effectiveness and safety of faricimab and PDS in nAMD and DME and identify clinician- and disease-related factors driving treatment outcomes in clinical practices globally to help optimize vision ...